Celgene Revamps IO Deal With Emerging Biotech Sutro; Takeover Option Removed

 
• By Lucie Ellis-Taitt
  
Businessman comparing two documents, neutral background
Celgene and Sutro redraft 2014 immuno-oncology deal • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business